back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-12-11 18:18 Tx date 2023-12-11 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Warrants
97 - Other
|
-1,000,000 vol |
3,845,072 | |
| Filed 2023-11-29 11:45 Tx date 2023-05-24 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+4,845,072 vol |
4,845,072 | |
| Filed 2023-05-24 12:18 Tx date 2023-05-24 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+5,062,016 vol |
||
| Filed 2023-05-24 12:18 Tx date 2023-05-24 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+5,062,016 vol |
5,062,016 | |
| Filed 2023-05-24 12:14 Tx date 2022-05-16 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-24 12:11 Tx date 2023-04-26 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100,000 vol $1,000 each |
$100,000 | |
| Filed 2023-05-01 13:35 Tx date 2023-04-27 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100 vol $1,000 each |
||
| Filed 2023-05-01 13:35 Tx date 2023-04-27 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100 vol $1,000 each |
$100 | |
| Filed 2023-05-01 13:29 Tx date 2022-05-16 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-19 18:54 Tx date 2022-06-14 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$136,000
+800,000 vol $0.17 each |
800,000 | |
| Filed 2022-06-19 18:52 Tx date 2022-05-16 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|